Synthetic Biology Patent Applications Expected to Present New Challenges
06 June 2008
Foley Partner Mark Waxman and Patent Agent Vid Mohan-Ram recently authored an article titled, “Synthetic Biology Patent Applications Expected to Present New Challenges,” in the June 6, 2008 issue of Life Sciences Law & Industry Report. The article addresses the U.S. patent applications that expressly focus on synthetic biology, and how the U.S. Patent & Trademark Office is handling and examining them.
Reproduced with permission from Life Sciences Law & Industry Report, Vol. 2, No. 12 (June 6, 2008) pp. 473-474. Copyright 2008 by The Bureau of National Affairs, Inc. (800-372-1033) http://www.bna.com.
Related Insights
21 May 2025
Tariff & International Trade Resource
What Every Multinational Company Should Know About … Customs Enforcement and False Claims Act Risks (Part III)
We complete the series on “Customs Enforcement and False Claims Act Risks” with Part III, which focuses on preparing for the most common FCA risks arising from improper management of import operations.
02 June 2025
Events
Biotech Panel Discussion & Happy Hour
Join Foley & Lardner LLP along with Biotech XYZ for an engaging evening event featuring a dynamic panel discussion and a lively happy hour.
03 June 2025
Events
Biotech Breakfast + Office Hours
Join Foley & Lardner LLP along with Biotech XYZ for Phase Capitals’ flagship networking biotech breakfast and office hours with Q&A sessions.